Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer

BACKGROUND: Retrospective analyses suggest that capecitabine may carry superior activity in hormone receptor‐positive relative to hormone receptor‐negative metastatic breast cancer. This review examined the veracity of that finding and explored whether this differential activity extends to early bre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Hoon, Siao-Nge, Lau, Peter K H, White, Alison M, Bulsara, Max K, Banks, Patricia D, Redfern, Andrew D
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2021
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8150746/
https://ncbi.nlm.nih.gov/pubmed/34037241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011220.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller